Moreover, cancer cell lines harboring PTEN loss or mutant PIK3CA required a higher drug concentration to establish 50% growth inhibition (IC50) in 2D cultures compared to that needed to inhibit AKT kinase activity [340]. This evidence concerns the gene PIK3CA and cancer.